| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.8M | +6068.1% |
| R&D Expense | $19.8M | -59.6% |
| SG&A Expense | $10.9M | -16.8% |
| Operating Income | -$1.8M | +97.1% |
| Interest Expense | $595K | -64.8% |
| Pre-tax Income | -$2.4M | +96.3% |
| Income Tax | $209K | — |
| Net Income | -$2.6M | +96.0% |
| EPS (Basic) | -$0.56 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | -75.2% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $10.1M | -77.0% |
| Total Assets | $23.3M | -64.0% |
| Current Liabilities | $1.6M | -95.2% |
| Total Liabilities | $8.4M | -84.3% |
| Stockholders' Equity | $14.9M | +32.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.7M | -2.4% |
| Capital Expenditures | $10K | -99.0% |
| Investing Cash Flow | $4.7M | -89.1% |
| Financing Cash Flow | -$3.1M | -378.2% |
| Free Cash Flow | -$35.7M | +0.3% |
| +22.2% |
| EPS (Diluted) | -$0.56 | +22.2% |